Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 7582730, 15 pages
https://doi.org/10.1155/2018/7582730
Review Article

Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib

1Laboratory of Pathophysiology of Cachexia and Metabolism of Skeletal Muscle, IRCCS San Raffaele Pisana, 00166 Rome, Italy
2Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
3Bionem Laboratory, Department of Experimental and Clinical Medicine, Magna Graecia University, 88100 Catanzaro, Italy
4Cardiovascular and Cell Sciences Institute, St George’s, University of London, Cranmer Terrace, London, UK

Correspondence should be addressed to Elisabetta Ferraro; ti.eleaffarnas@orarref.attebasile

Received 3 November 2017; Revised 23 January 2018; Accepted 6 February 2018; Published 18 March 2018

Academic Editor: Vladimir Jakovljevic

Copyright © 2018 Stefania Gorini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [17 citations]

The following is the list of published articles that have cited the current article.

  • Dolonchampa Maji, Jin Lu, Pinaki Sarder, Anne H Schmieder, Grace Cui, Xiaoxia Yang, Dipanjan Pan, Samuel Achilefu, and Gregory M Lanza, “Cellular Trafficking of Sn-2 Phosphatidylcholine Prodrugs Studied with Fluorescence Lifetime Imaging and Super-resolution Microscopy,” Precision Nanomedicine, vol. 1, no. 2, pp. 128–145, 2018. View at Publisher · View at Google Scholar
  • Yongxin Qiu, Yi Dai, Chi Zhang, Ye Yang, Ming Jin, Wenqi Shan, Jian Shen, Ming Lu, Zhaoyang Tang, Liang Ju, Yuting Wang, Ruonan Jiao, Yunwei Xia, Guangming Huang, Lihua Yang, Yuan Li, Jianping Zhang, Vincent Kam Wai Wong, and Zhihong Jiang, “Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14–3-3η/NF-κB feedback loop,” Journal of Experimental & Clinical Cancer Research, vol. 37, no. 1, 2018. View at Publisher · View at Google Scholar
  • Scott K. Powers, Jose A. Duarte, Branden Le Nguyen, and Hayden Hyatt, “Endurance exercise protects skeletal muscle against both doxorubicin-induced and inactivity-induced muscle wasting,” Pflügers Archiv - European Journal of Physiology, 2018. View at Publisher · View at Google Scholar
  • Weijian Hang, Benhong He, Jiehui Chen, Liangtao Xia, Bing Wen, Tao Liang, Xu Wang, Qianying Zhang, Yue Wu, Qingjie Chen, and Juan Chen, “Berberine Ameliorates High Glucose-Induced Cardiomyocyte Injury via AMPK Signaling Activation to Stimulate Mitochondrial Biogenesis and Restore Autophagic Flux,” Frontiers in Pharmacology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Bikui Zhang, Zimeng Wan, Shanshan Wei, Zhaohui Guo, Wenqun Li, Miao Yan, Lei Chen, Pingfei Fang, Zhihua Li, Sisi Cao, and Zhenyan Hou, “Nrf2-dependent antioxidant response mediated the protective effect of tanshinone IIA on doxorubicin-induced cardiotoxicity,” Experimental and Therapeutic Medicine, vol. 16, no. 4, pp. 3333–3344, 2018. View at Publisher · View at Google Scholar
  • Yonghong Xia, Lejun Lin, Zuoguang Zhang, Hui Tian, Jian Han, and Kefeng Li, “Next-generation metabolomics in the development of new antidepressants: Using albiflorin as an example,” Current Pharmaceutical Design, vol. 24, no. 22, pp. 2530–2540, 2018. View at Publisher · View at Google Scholar
  • Peggy M. Kostakou, Nikos T. Kouris, Dimitrios S. Damaskos, Vassilios S. Kostopoulos, and Christoforos D. Olympios, “Cardio-oncology: a new and developing sector of research and therapy in the field of cardiology,” Heart Failure Reviews, 2018. View at Publisher · View at Google Scholar
  • Shun-Zhen Zheng, Ping Sun, Jian-Ping Wang, Yong Liu, Wei Gong, and Jun Liu, “MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells,” World Journal of Gastroenterology, vol. 25, no. 22, pp. 2752–2762, 2019. View at Publisher · View at Google Scholar
  • Xuerong Zhao, Yue Jin, Lei Li, Lina Xu, Zeyao Tang, Yan Qi, Lianhong Yin, and Jinyong Peng, “MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1,” Pharmacological Research, pp. 104276, 2019. View at Publisher · View at Google Scholar
  • Agnieszka Korga, Marta Ostrowska, Aleksandra Jozefczyk, Magdalena Iwan, Rafal Wojcik, Grazyna Zgorka, Mariola Herbet, Gemma Gomez Vilarrubla, and Jaroslaw Dudka, “Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells,” BMC Pharmacology and Toxicology, vol. 20, no. 1, 2019. View at Publisher · View at Google Scholar
  • Ross A. Kelly, Joseph Leedale, Dominic Calleja, Steven J. Enoch, Andy Harrell, Amy E. Chadwick, and Steven Webb, “Modelling changes in glutathione homeostasis as a function of quinone redox metabolism,” Scientific Reports, vol. 9, no. 1, 2019. View at Publisher · View at Google Scholar
  • Mingfang Ye, Linlin Zhang, Yuanming Yan, and Huizhong Lin, “Punicalagin protects H9c2 cardiomyocytes from doxorubicin-induced toxicity through activation of Nrf2/HO-1 signaling,” Bioscience Reports, vol. 39, no. 5, pp. BSR20190229, 2019. View at Publisher · View at Google Scholar
  • Shan, Zheng, and Li, “The effects of Astragalus Membranaceus Active Extracts on Autophagy-related Diseases,” International Journal of Molecular Sciences, vol. 20, no. 8, pp. 1904, 2019. View at Publisher · View at Google Scholar
  • Chia-Yang Lin, Atikul Islam, Claire J. Su, Alexander S. Tikhomirov, Andrey E. Shchekotikhin, Show-Mei Chuang, Pin Ju Chueh, and Yao Li Chen, “Engagement with tNOX (ENOX2) to Inhibit SIRT1 and Activate p53-Dependent and -Independent Apoptotic Pathways by Novel 4,11-Diaminoanthra[2,3-b]furan-5,10-diones in Hepatocellular Carcinoma Cells,” Cancers, vol. 11, no. 3, pp. 420, 2019. View at Publisher · View at Google Scholar
  • Christina Schindler, Andie Collinson, Carl Matthews, Amy Pointon, Lesley Jenkinson, Ralph R. Minter, Tristan J. Vaughan, and Natalie J. Tigue, “Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency,” Plos One, vol. 14, no. 3, pp. e0214545, 2019. View at Publisher · View at Google Scholar
  • Jingjing Du, Pengzhou Hang, Yang Pan, Burong Feng, Yuyang Zheng, Tingting Chen, Lihui Zhao, and Zhimin Du, “Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway,” Toxicology and Applied Pharmacology, 2019. View at Publisher · View at Google Scholar
  • Qinggong Wan, Tao Xu, Wei Ding, Xuejuan Zhang, Xiaoyu Ji, Tao Yu, Wanpeng Yu, Zhijuan Lin, and Jianxun Wang, “miR-499-5p Attenuates Mitochondrial Fission and Cell Apoptosis via p21 in Doxorubicin Cardiotoxicity,” Frontiers in Genetics, vol. 9, 2019. View at Publisher · View at Google Scholar